Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research.
Shaw JA, Meiring M, Allies D, Cruywagen L, Fisher TL, Kasavan K, Roos K, Botha SM, MacDonald C, Hiemstra AM, Simon D, van Rensburg I, Flinn M, Shabangu A, Kuivaniemi H, Tromp G, Malherbe ST, Walzl G, du Plessis N; Stellenbosch University Immunology Research Group Bronchoalveolar Lavage Study Consortium (SU IRG BAL Study Consortium). Shaw JA, et al. Among authors: fisher tl. Sci Rep. 2023 May 31;13(1):8859. doi: 10.1038/s41598-023-35723-2. Sci Rep. 2023. PMID: 37258565 Free PMC article.
Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB).
Richardson TR, Smith B, Malherbe ST, Shaw JA, Noor F, MacDonald C, van der Spuy GD, Stanley K, Carstens A, Fisher TL, van Rensburg I, Flinn M, Snyders C, Johnson I, Fransman B, Dockrell H, Thwaites G, Thuong NTT, Schacht C, Mayanja-Kizza H, Nsereko M, Tjon Kon Fat EM, Corstjens PLAM, Geluk A, Ruhwald M, Penn-Nicholson A, Chegou NN, Sutherland J, Walzl G; TrENDx consortium. Richardson TR, et al. Among authors: fisher tl. BMC Infect Dis. 2023 Jul 3;23(1):447. doi: 10.1186/s12879-023-08342-5. BMC Infect Dis. 2023. PMID: 37400753 Free PMC article.
Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
Reyskens KM, Fisher TL, Schisler JC, O'Connor WG, Rogers AB, Willis MS, Planesse C, Boyer F, Rondeau P, Bourdon E, Essop MF. Reyskens KM, et al. Among authors: fisher tl. PLoS One. 2013 Sep 30;8(9):e73347. doi: 10.1371/journal.pone.0073347. eCollection 2013. PLoS One. 2013. PMID: 24098634 Free PMC article.
Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research.
Shaw JA, Meiring M, Allies D, Cruywagen L, Fisher TL, Kasavan K, Roos K, Botha SM, MacDonald C, Hiemstra AM, Simon D, van Rensburg I, Flinn M, Shabangu A, Kuivaniemi H, Tromp G, Malherbe ST, Walzl G, du Plessis N; Stellenbosch University Immunology Research Group Bronchoalveolar Lavage Study Consortium (SU IRG BAL Study Consortium). Shaw JA, et al. Among authors: fisher tl. Res Sq [Preprint]. 2023 Feb 2:rs.3.rs-2505850. doi: 10.21203/rs.3.rs-2505850/v1. Res Sq. 2023. PMID: 36778283 Free PMC article. Updated. Preprint.
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Feigin A, Evans EE, Fisher TL, Leonard JE, Smith ES, Reader A, Mishra V, Manber R, Walters KA, Kowarski L, Oakes D, Siemers E, Kieburtz KD, Zauderer M; Huntington Study Group SIGNAL investigators. Feigin A, et al. Among authors: fisher tl. Nat Med. 2024 Feb;30(2):606. doi: 10.1038/s41591-022-02070-0. Nat Med. 2024. PMID: 36195687 Free PMC article. No abstract available.
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Feigin A, Evans EE, Fisher TL, Leonard JE, Smith ES, Reader A, Mishra V, Manber R, Walters KA, Kowarski L, Oakes D, Siemers E, Kieburtz KD, Zauderer M; Huntington Study Group SIGNAL investigators. Feigin A, et al. Among authors: fisher tl. Nat Med. 2022 Oct;28(10):2183-2193. doi: 10.1038/s41591-022-01919-8. Epub 2022 Aug 8. Nat Med. 2022. PMID: 35941373 Free PMC article. Clinical Trial.
ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report.
Martits-Chalangari K, Spak CW, Askar M, Killian A, Fisher TL, Atillasoy E, Marshall WL, McNeel D, Miller MD, Mathai SK, Gottlieb RL. Martits-Chalangari K, et al. Among authors: fisher tl. Am J Transplant. 2022 Apr;22(4):1261-1265. doi: 10.1111/ajt.16927. Epub 2021 Dec 27. Am J Transplant. 2022. PMID: 34910857 Free PMC article.
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.
Shafique MR, Fisher TL, Evans EE, Leonard JE, Pastore DRE, Mallow CL, Smith E, Mishra V, Schröder A, Chin KM, Beck JT, Baumgart MA, Govindan R, Gabrail NY, Spira AI, Seetharamu N, Lou Y, Mansfield AS, Sanborn RE, Goldman JW, Zauderer M. Shafique MR, et al. Among authors: fisher tl. Clin Cancer Res. 2021 Jul 1;27(13):3630-3640. doi: 10.1158/1078-0432.CCR-20-4792. Epub 2021 Apr 5. Clin Cancer Res. 2021. PMID: 33820783 Clinical Trial.
180 results